6 April 2021

The FDA issued an Emergency Use Authorization (EUA) to Symbiotica, Inc., for the COVID-19 Self-Collected Antibody Test System, making it the first serology test authorized for use with a blood sample self-collected at-home.

The Symbiotica COVID-19 Self-Collected Antibody Test System requires a prescription from a health care provider. ··(중략)

원문 바로보기 https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-april-6-2021